Publicaciones de Ayala de Miguel, Carlos ( Resultados)

Artículos

, Ayala-de Miguel C, Quintana-Cortés L, González-Santiago S, Fuentes-Pradera J, Ayala-de Miguel P, et al. Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer. Cancers. 2026; 18 (10): 1538.

Díaz-López S, Ayala de Miguel C, Fernández-Pérez EM, Beltrán-Guerra I, Bachurin L, García-González G, et al. Search for prognostic markers of mortality in inpatients receiving palliative chemotherapy. Clin Transl Oncol. 2026;

Artículos de Blog/Web

, Ayala de Miguel C, González Santiago S, Ayala de Miguel P. Impact of Immune-Related Adverse Event Frequency, Severity, and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non– Small Cell Lung Cancer. 15 de abril de 2026 En: Preprints.org [Internet].